艾昆緯 IQV 深 滬
等待開盤 09-17 09:30:00 美东时间
186.81
+0.840
+0.45%
華盛通- 最 高188.29
- 今 開186.16
- 成交量 99.25万股
- 最 低 184.75
- 昨 收 185.97
- 總市值 317.58亿
- 52周最高 237.335
- 市盈率 靜 24.95
- 換手率 0.58%
- 52周最低 134.645
- 委 比 0.00%
- 總股本 1.70亿
- 歷史最高 285.61
- 量 比 0.85
- 振 幅 1.90%
- 歷史最低 81.79
- 每 手 1
- 風險率 27.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EXCLUSIVE: Scienture Secures PBM-Led Rebate Agreement To Position Hypertension Drug For Rapid Adoption In US Market
Scienture's Arbli, the first ready-to-use liquid losartan, gains formulary access with coverage for over 100 million lives and discussions for broader access.
09-16 19:45
Charles River Laboratories appoints Michael Knell as interim CFO
Charles River Laboratories International (NYSE:CRL) announced that Flavia H. Pease, the company's Corporate Executive Vice President and CFO, has stepped down from her position as of September 29, 202...
09-16 19:25
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold
Jefferies, in its review of Contract Research Organisations (CRO), has upgraded IQVIA (NYSE:IQV) and Charles River Laboratories (NYSE:CRL) to Buy from Hold while ICON PLC (NASDAQ:ICLR) was cut to Hold...
09-09 22:07
Assessing IQVIA Hldgs: Insights From 7 Financial Analysts
Across the recent three months, 7 analysts have shared their insights on IQVIA ...
09-09 21:01
Jefferies Upgrades IQVIA Hldgs to Buy, Raises Price Target to $225
Jefferies analyst David Windley upgrades IQVIA Hldgs (NYSE:IQV) from Hold to Buy and raises the price target from $195 to $225.
09-09 19:00
股价翻倍高管减持，累亏50亿的迪哲医药离盈利还有多远？
在A股创新药行情火爆背景下，7年半累亏近50亿元的迪哲医药同样受到资本市场追捧。2025年以来，（截止9月8日）股价已接近翻倍，较2022年底部更是反弹近30...
09-08 20:03
IQVIA Holdings Announces New CFO Appointment
IQVIA Holdings ( ($IQV) ) has shared an update. On September 2, 2025, IQVIA Hol...
09-02 21:51
